15 citations
,
March 2004 in “British Journal of Dermatology” This case report describes a 40-year-old Indian male with sclerosing cholangitis whose skin lesions and liver function improved following surgical treatment.
5 citations
,
August 2014 in “Australasian journal of dermatology” This article discusses a case of delayed onset perforating folliculitis linked to the use of sorafenib, but it reports no new clinical results.
2 citations
,
January 1990 in “PubMed” This case study highlights a 20-year-old male with perforating folliculitis, proposing its classification within primary perforating dermatoses, and discusses failed keratolytic treatments and potential underlying causes.
January 2026 in “JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH” In this case study, a 62-year-old male with a history of uncontrolled diabetes and chronic kidney disease was diagnosed with perforating folliculitis after presenting with dark, raised, pruritic lesions on his limbs, confirmed by histopathological examination showing collagen extruding into hair follicles.
September 2010 in “Institutional Repositories DataBase (IRDB)” Sorafenib can cause a temporary skin condition that goes away after stopping the drug.